LumiraDx (LMDX) News Today → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free LMDX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLumiraDx Ltd LMDXFmorningstar.com - April 14 at 1:45 PMLMDX.Oreuters.com - January 31 at 11:49 PMWhy LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarketmsn.com - January 8 at 10:06 AMWhy Is LumiraDx (LMDX) Stock Down 13% Today?investorplace.com - January 8 at 10:03 AMLumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9thfinance.yahoo.com - January 5 at 8:40 PMRoche (RHHBY) to Acquire LumiraDx's Point of Care Technologymsn.com - January 2 at 1:33 PMRoche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295Mbenzinga.com - January 2 at 8:33 AMWhy LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarketbenzinga.com - January 2 at 8:33 AMLumiraDx falls on agreement with Roche to sell assetsmsn.com - January 2 at 8:33 AMRoche to buy part of LumiraDx diagnostics platform for $295 millionreuters.com - December 29 at 10:58 PMLumiraDx Inc: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Rochefinanznachrichten.de - December 29 at 5:57 PMRoche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platformfinance.yahoo.com - December 29 at 5:57 PMLumiraDx Agrees To Sell Point-of-Care Tech Platform To Rochemarkets.businessinsider.com - December 29 at 5:57 PMLumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Rochefinance.yahoo.com - December 29 at 5:57 PMLumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Rochefinance.yahoo.com - December 29 at 5:57 PMmarketbeat.com - December 29 at 4:25 PMLumiraDx Limited (LMDX)uk.finance.yahoo.com - December 26 at 7:56 PMLumiraDx (LMDX) Price Target Increased by 12.50% to 1.22msn.com - November 27 at 11:57 PMLumiraDx Ltd LMDXmorningstar.com - November 15 at 11:59 PMWhy Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarketbenzinga.com - November 2 at 9:03 AMWhy Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarketbenzinga.com - October 31 at 10:21 AMLumiraDx Inc: LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appealfinanznachrichten.de - October 28 at 7:46 AMLumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appealfinance.yahoo.com - October 27 at 7:59 PMWhy Is LumiraDx (LMDX) Stock Down 35% Today?msn.com - October 24 at 11:21 AMLumiraDx Inc: LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England's First Heart & Lung Screening Hubfinanznachrichten.de - October 20 at 11:21 PMLumiraDx Limited (LMDX) Loses -25.54% in 4 Weeks, Here's Why a Trend Reversal May be Around the Cornerfinance.yahoo.com - September 27 at 1:26 PMWhat Makes LumiraDx Limited (LMDX) a New Buy Stockfinance.yahoo.com - September 21 at 1:55 PMBTIG Keeps Their Buy Rating on LumiraDx (LMDX)markets.businessinsider.com - August 27 at 3:59 PMEarnings Update: LumiraDx Limited (NASDAQ:LMDX) Just Reported And Analysts Are Trimming Their Forecastsfinance.yahoo.com - August 27 at 9:15 AMLumiraDx Limited (NASDAQ:LMDX) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 25 at 4:31 PMLumiraDx Reports Second Quarter 2023 Resultsfinance.yahoo.com - August 24 at 6:23 PMLumiraDx Limited (LMDX) Reports Q2 Loss, Misses Revenue Estimatesfinance.yahoo.com - August 24 at 6:23 PMThis LumiraDx Insider Increased Their Holding By 150% Last Yearfinance.yahoo.com - August 21 at 4:34 PMLumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24finance.yahoo.com - August 16 at 6:28 PMCapitalGainsReport Potential Breakouts Watchlist (SHGI, IQST, PHUN LMDX)benzinga.com - August 1 at 6:12 PMPositive Sentiment Still Eludes LumiraDx Limited (NASDAQ:LMDX) Following 27% Share Price Slumpfinance.yahoo.com - August 1 at 6:12 PMLumiraDx Submits Medical Device Application To FDA For COVID Ultra Testmarkets.businessinsider.com - June 30 at 8:10 PMLumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Testfinance.yahoo.com - June 30 at 3:09 PMLumiraDx shares are trading higher after the company received UK approval for its COVID Ultra and COVID & RSV Tests.benzinga.com - June 21 at 10:22 AMLumiraDX Skyrockets on Bagging Approval for COVID-19 and RSV Tests in the U.K.msn.com - June 21 at 10:22 AMWhy Is LumiraDx (LMDX) Stock Up 30% Today?investorplace.com - June 21 at 10:02 AMLumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Testsfinance.yahoo.com - June 20 at 5:32 PMLMDX - LumiraDx Limitedca.finance.yahoo.com - June 6 at 3:58 AMLadenburg Thalmann Maintains LumiraDx (LMDX) Buy Recommendationmsn.com - May 18 at 10:10 AMGoldman Sachs Maintains LumiraDx (LMDX) Neutral Recommendationmsn.com - May 18 at 10:10 AMThe Latest Analyst Ratings for LumiraDxmarkets.businessinsider.com - May 17 at 6:49 PMRaymond James Maintains LumiraDx (LMDX) Outperform Recommendationmsn.com - May 17 at 1:49 PMAnalysts Offer Insights on Healthcare Companies: LumiraDx (LMDX) and Aerovate Therapeutics (AVTE)markets.businessinsider.com - May 16 at 9:51 PMLumiraDx: Q1 Earnings Insightsmsn.com - May 16 at 4:50 PMLumiraDx Limited (LMDX) Reports Q1 Loss, Tops Revenue Estimatesfinance.yahoo.com - May 16 at 4:50 PM Get LumiraDx News Delivered to You Automatically Sign up to receive the latest news and ratings for LMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. LMDX Media Mentions By Week LMDX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LMDX News Sentiment▼0.000.36▲Average Medical News Sentiment LMDX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LMDX Articles This Week▼01▲LMDX Articles Average Week Get LumiraDx News Delivered to You Automatically Sign up to receive the latest news and ratings for LMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Synaptogenix News Today Alzamend Neuro News Today First Wave BioPharma News Today Sonnet BioTherapeutics News Today Kazia Therapeutics News Today Cingulate News Today Oragenics News Today PaxMedica News Today NexImmune News Today Lipella Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LMDX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryObama’s Forever Term [exposed]Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LumiraDx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.